BRITNEY GORE: Open Payments
NPI 1447885710 · PANAMA CITY BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$664 in 25 payments from 10 companies in 2025. Trend: 2023 $625 · 2024 $570 · 2025 $664
Food & beverage: $611Education: $53
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 7 | $245 |
| Regeneron Healthcare Solutions, Inc. | 6 | $131 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $71 |
| SANOFI-AVENTIS U.S. LLC | 1 | $53 |
| Lilly USA, LLC | 2 | $36 |
| AstraZeneca Pharmaceuticals LP | 2 | $34 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $29 |
| Merck Sharp & Dohme LLC | 1 | $25 |
| Novo Nordisk Inc | 1 | $23 |
| GlaxoSmithKline, LLC. | 1 | $16 |
Products named: DUPIXENT, Kerendia, MOUNJARO, AIRSUPRA, TRINTELLIX, GARDASIL 9, Ozempic, NUCALA.
Industry payments across FL — which companies pay providers there.
